Community Bank’s Vertex Pharmaceuticals VRTX Stock Holding History

Community Bank’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$248K	Sell	500 -380	-43%	-$168K	0.03%	202
2026 Q1	$393K	Sell	880 -2,247	-72%	-$1.05M	0.05%	173
2025 Q4	$1.42M	Buy	3,127 +265	+9%	+$114K	0.17%	119
2025 Q3	$1.12M	Buy	2,862 +898	+46%	+$375K	0.14%	131
2025 Q2	$874K	Buy	1,964 +727	+59%	+$335K	0.12%	141
2025 Q1	$600K	Sell	1,237 -23	-2%	-$10.7K	0.08%	159
2024 Q4	$507K	Buy	1,260 +290	+30%	+$134K	0.07%	169
2024 Q3	$451K	Sell	970 -5	-0.5%	-$2.4K	0.06%	174
2024 Q2	$457K	Buy	+975	New	+$423K	0.06%	172
2023 Q1	–	Sell	-18	Closed	-$5.2K	–	483
2022 Q4	$5.2K	Hold	18	–	–	﹤0.01%	421
2022 Q3	$5K	Buy	+18	New	+$5.18K	﹤0.01%	446

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Community Bank's VRTX Position: Q2 2026 in Review

Community Bank reduced its Vertex Pharmaceuticals (VRTX) stake by 43% in Q2 2026, selling an estimated $168K and leaving 500 shares worth $248K. The position accounts for 0.03% of the portfolio, ranked #202.

Community Bank first reported a position in VRTX in Q3 2022 and has held it in 11 quarters since. The position peaked at $1.42M in Q4 2025. 1,762 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Community Bank held 500 shares of Vertex Pharmaceuticals worth $248K as of Q2 2026.
Community Bank sold 380 Vertex Pharmaceuticals shares in Q2 2026, an estimated $168K.
Vertex Pharmaceuticals made up 0.03% of Community Bank's portfolio in Q2 2026, its #202 holding.
Community Bank first reported a position in Vertex Pharmaceuticals in Q3 2022 and has held it in 11 quarters since.
Community Bank's Vertex Pharmaceuticals position peaked at $1.42M in Q4 2025.
1,762 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Community Bank's 13F filing for Q2 2026, filed 13 Aug 2026.